Company Filing History:
Years Active: 2020
Title: Janet Van Eersel: Innovator in Tauopathy Research
Introduction
Janet Van Eersel is a prominent inventor based in Glebe, Australia. She has made significant contributions to the field of biomedical research, particularly in the study of tauopathies, which are neurodegenerative diseases associated with tau protein abnormalities. Her innovative work has led to the development of methods that could pave the way for new therapeutic options.
Latest Patents
Janet holds a patent for an "Assay and method for identifying compounds that reduce SIL1 expression or activity." This invention relates to methods and assays designed to identify compounds as candidates for drug development aimed at treating various diseases, including those associated with pathological tau. The patent also encompasses cell lines and constructs that facilitate the assay process. The methods identify a compound as useful in treating tauopathies if it modulates Sil1 expression or activity. She has 1 patent to her name.
Career Highlights
Janet is affiliated with Macquarie University, where she conducts her research and contributes to the academic community. Her work is characterized by a strong focus on the molecular mechanisms underlying tauopathies, which are critical for understanding and developing treatments for these debilitating conditions.
Collaborations
Janet collaborates with Lars Matthias Ittner, a fellow researcher in the field. Their partnership enhances the scope and impact of their research, allowing for a more comprehensive approach to tackling the challenges posed by tauopathies.
Conclusion
Janet Van Eersel is a dedicated inventor whose work in tauopathy research holds promise for future therapeutic advancements. Her innovative methods and collaborative efforts contribute significantly to the understanding and treatment of neurodegenerative diseases.